Commonwealth Equity Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$147M Sell
1,222,577
-85,622
-7% -$9.88M 0.21% 89
2025
Q4
$138M Sell
1,308,199
-62,630
-5% -$5.88M 0.18% 103
2025
Q3
$115M Sell
1,370,829
-127,954
-9% -$10.5M 0.15% 127
2025
Q2
$119M Buy
1,498,783
+15,591
+1% +$1.24M 0.16% 119
2025
Q1
$133M Sell
1,483,192
-22,126
-1% -$2.07M 0.19% 100
2024
Q4
$150M Sell
1,505,318
-5,461
-0.4% -$563K 0.22% 82
2024
Q3
$172M Buy
1,510,779
+13,358
+0.9% +$1.59M 0.26% 71
2024
Q2
$185M Buy
1,497,421
+31,022
+2% +$4M 0.29% 67
2024
Q1
$193M Sell
1,466,399
-5,688
-0.4% -$701K 0.32% 57
2023
Q4
$160M Buy
1,472,087
+24,966
+2% +$2.59M 0.29% 64
2023
Q3
$149M Sell
1,447,121
-19,856
-1% -$2.14M 0.31% 64
2023
Q2
$169M Buy
1,466,977
+1,374
+0.1% +$156K 0.34% 51
2023
Q1
$156K Sell
1,465,603
-54,384
-4% -$5.87M 0.33% 56
2022
Q4
$169M Sell
1,519,987
-34,923
-2% -$3.57M 0.41% 45
2022
Q3
$134M Sell
1,554,910
-7,927
-0.5% -$708K 0.35% 58
2022
Q2
$142M Buy
1,562,837
+32,003
+2% +$2.84M 0.37% 54
2022
Q1
$126M Buy
1,530,834
+86,360
+6% +$6.81M 0.29% 66
2021
Q4
$111M Buy
1,444,474
+74,728
+5% +$5.95M 0.25% 79
2021
Q3
$103M Buy
1,369,746
+39,745
+3% +$3.02M 0.26% 76
2021
Q2
$103M Sell
1,330,001
-1,754
-0.1% -$130K 0.26% 80
2021
Q1
$98M Buy
1,331,755
+89,234
+7% +$6.58M 0.28% 75
2020
Q4
$97M Buy
1,242,521
+12,382
+1% +$947K 0.29% 73
2020
Q3
$97.4M Buy
1,230,139
+10,014
+0.8% +$784K 0.33% 62
2020
Q2
$90M Buy
1,220,125
+91,508
+8% +$6.89M 0.34% 67
2020
Q1
$82.9M Buy
1,128,617
+11,905
+1% +$936K 0.39% 57
2019
Q4
$96.9M Buy
1,116,712
+39,761
+4% +$3.27M 0.37% 61
2019
Q3
$86.5M Buy
1,076,951
+34,248
+3% +$2.74M 0.37% 63
2019
Q2
$83.4M Sell
1,042,703
-17,751
-2% -$1.36M 0.37% 61
2019
Q1
$84.2M Buy
1,060,454
+2,683
+0.3% +$201K 0.39% 57
2018
Q4
$77.1M Sell
1,057,771
-29,747
-3% -$2.1M 0.41% 54
2018
Q3
$73.6M Buy
1,087,518
+7,428
+0.7% +$473K 0.35% 63
2018
Q2
$62.6M Buy
1,080,090
+51,446
+5% +$2.9M 0.33% 69
2018
Q1
$53.5M Buy
1,028,644
+23,606
+2% +$1.27M 0.29% 80
2017
Q4
$54M Buy
1,005,038
+55,089
+6% +$3.05M 0.29% 76
2017
Q3
$58M Buy
949,949
+10,588
+1% +$642K 0.35% 68
2017
Q2
$57.4M Buy
939,361
+2,205
+0.2% +$134K 0.37% 61
2017
Q1
$56.8M Buy
937,156
+8,102
+0.9% +$492K 0.38% 58
2016
Q4
$52.2M Buy
929,054
+13,805
+2% +$808K 0.39% 55
2016
Q3
$54.5M Buy
915,249
+10,126
+1% +$592K 0.43% 52
2016
Q2
$49.8M Buy
905,123
+19,517
+2% +$1.04M 0.42% 53
2016
Q1
$44.7M Buy
885,606
+31,103
+4% +$1.52M 0.4% 53
2015
Q4
$43.1M Buy
854,503
+20,324
+2% +$1.02M 0.41% 51
2015
Q3
$39.3M Buy
834,179
+48,052
+6% +$2.55M 0.41% 50
2015
Q2
$42.7M Buy
786,127
+27,680
+4% +$1.55M 0.42% 45
2015
Q1
$41.6M Buy
758,447
+36,871
+5% +$2.09M 0.43% 42
2014
Q4
$39.1M Buy
721,576
+6,603
+0.9% +$368K 0.44% 43
2014
Q3
$40.4M Buy
714,973
+34,309
+5% +$1.93M 0.49% 39
2014
Q2
$37.6M Buy
680,664
+38,361
+6% +$2.09M 0.46% 42
2014
Q1
$34.8M Buy
642,303
+10,486
+2% +$543K 0.48% 41
2013
Q4
$30.2M Buy
631,817
+20,892
+3% +$955K 0.44% 46
2013
Q3
$27.8M Buy
610,925
+24,705
+4% +$1.13M 0.45% 45
2013
Q2
$26M Buy
+586,220
New +$26.2M 0.46% 46

Other funds holding MRK

Commonwealth Equity Services's MRK Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Merck (MRK) stake by 6.5% in Q1 2026, selling an estimated $9.88M and leaving 1,222,577 shares worth $147M. The position accounts for 0.21% of the portfolio, ranked #89.

Commonwealth Equity Services first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $193M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Commonwealth Equity Services held 1,222,577 shares of Merck worth $147M as of Q1 2026.
  • Commonwealth Equity Services sold 85,622 Merck shares in Q1 2026, an estimated $9.88M.
  • Merck made up 0.21% of Commonwealth Equity Services's portfolio in Q1 2026, its #89 holding.
  • Commonwealth Equity Services first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's Merck position peaked at $193M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.